PARP7-IN-15 is an orally active and selective PARP7 inhibitor with an IC50 of 0.56 nM. PARP7-IN-15 inhibits the enzymatic activity of PARP7 and induces anti-tumor activity against lung cancer in vivo. PARP7-IN-15 can be used for the research of lung cancer[1].
Molecular Weight:
562.46
Purity:
99.03
CAS Number:
[2819998-97-3]
Formula:
C23H24F6N6O4
Target:
Cytochrome P450,PARP
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
